# OnCo record neonax (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/neonax/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "neonax", "NCT02047513" ;
  schema:name "NEONAX"@en ;
  schema:alternateName "AIO-PAK-0313"@en ;
  schema:description "NEONAX compared giving gemcitabine and nab-paclitaxel around surgery with giving it only afterwards; neither arm reached the trial's 55 percent target for being relapse-free at 18 months, but patients treated before surgery lived a median 25.5 months against 16.7, mostly because so few in the surgery-first arm were ever fit enough to start chemotherapy."@en ;
  schema:url <https://onco.cc/trials/neonax/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02047513>, <https://doi.org/10.1016/j.annonc.2022.09.161> ;
  onco:status "mixed" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> ;
  onco:companies <https://onco.cc/companies/aio/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/> .